<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wiki.vexillomancy.org/index.php?action=history&amp;feed=atom&amp;title=Megachrome</id>
	<title>Megachrome - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.vexillomancy.org/index.php?action=history&amp;feed=atom&amp;title=Megachrome"/>
	<link rel="alternate" type="text/html" href="https://wiki.vexillomancy.org/index.php?title=Megachrome&amp;action=history"/>
	<updated>2026-08-05T11:38:45Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.6</generator>
	<entry>
		<id>https://wiki.vexillomancy.org/index.php?title=Megachrome&amp;diff=824&amp;oldid=prev</id>
		<title>Semaiophoron: fix discovery date</title>
		<link rel="alternate" type="text/html" href="https://wiki.vexillomancy.org/index.php?title=Megachrome&amp;diff=824&amp;oldid=prev"/>
		<updated>2024-09-17T04:58:24Z</updated>

		<summary type="html">&lt;p&gt;fix discovery date&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 04:58, 17 September 2024&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&#039;&#039;&#039;Megachrome&#039;&#039;&#039; (often simply called &#039;&#039;&#039;mega&#039;&#039;&#039;, sometimes euphemistically referred to as &#039;&#039;&#039;MCUltra&#039;&#039;&#039; or simply &#039;&#039;&#039;ultra&#039;&#039;&#039;) is a hypersynthetic stimulant and nootropic discovered in &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;2993 &lt;/del&gt;that is 4,000 times more potent than amphetamine without any cardiovascular side effects and a half life of 43 hours when administered orally.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&#039;&#039;&#039;Megachrome&#039;&#039;&#039; (often simply called &#039;&#039;&#039;mega&#039;&#039;&#039;, sometimes euphemistically referred to as &#039;&#039;&#039;MCUltra&#039;&#039;&#039; or simply &#039;&#039;&#039;ultra&#039;&#039;&#039;) is a hypersynthetic stimulant and nootropic discovered in &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;2758 &lt;/ins&gt;that is 4,000 times more potent than amphetamine without any cardiovascular side effects and a half life of 43 hours when administered orally.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Pharmacokinetics ==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Pharmacokinetics ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Semaiophoron</name></author>
	</entry>
	<entry>
		<id>https://wiki.vexillomancy.org/index.php?title=Megachrome&amp;diff=823&amp;oldid=prev</id>
		<title>Semaiophoron at 04:53, 17 September 2024</title>
		<link rel="alternate" type="text/html" href="https://wiki.vexillomancy.org/index.php?title=Megachrome&amp;diff=823&amp;oldid=prev"/>
		<updated>2024-09-17T04:53:00Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 04:53, 17 September 2024&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l17&quot;&gt;Line 17:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 17:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Legality ==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Legality ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Megachrome is legal worldwide, with many governments even subsidizing its use due to its effects on economic output &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;and &lt;/del&gt;longevity increasing effects.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Megachrome is legal worldwide, with many governments even subsidizing its use due to its effects on economic output &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;alongside its &lt;/ins&gt;longevity increasing effects.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Semaiophoron</name></author>
	</entry>
	<entry>
		<id>https://wiki.vexillomancy.org/index.php?title=Megachrome&amp;diff=822&amp;oldid=prev</id>
		<title>Semaiophoron: add legality</title>
		<link rel="alternate" type="text/html" href="https://wiki.vexillomancy.org/index.php?title=Megachrome&amp;diff=822&amp;oldid=prev"/>
		<updated>2024-09-17T04:52:31Z</updated>

		<summary type="html">&lt;p&gt;add legality&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 04:52, 17 September 2024&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l15&quot;&gt;Line 15:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 15:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Concerns have been raised over what has been dubbed &amp;quot;Megapsychosis&amp;quot; in heavy users, with some detractors arguing that the increasingly incomprehensible thoughts after heavy use for several weeks should be considered indicative of neurological damage. But defenders argue that brain scans show a different story, with heavy increases in gray matter, white matter and the corpus callosum, and suggest that detractors are simply not sufficiently advanced to understand the concepts being discussed by heavy users.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Concerns have been raised over what has been dubbed &amp;quot;Megapsychosis&amp;quot; in heavy users, with some detractors arguing that the increasingly incomprehensible thoughts after heavy use for several weeks should be considered indicative of neurological damage. But defenders argue that brain scans show a different story, with heavy increases in gray matter, white matter and the corpus callosum, and suggest that detractors are simply not sufficiently advanced to understand the concepts being discussed by heavy users.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;== Legality ==&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Megachrome is legal worldwide, with many governments even subsidizing its use due to its effects on economic output and longevity increasing effects.&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Semaiophoron</name></author>
	</entry>
	<entry>
		<id>https://wiki.vexillomancy.org/index.php?title=Megachrome&amp;diff=821&amp;oldid=prev</id>
		<title>Semaiophoron: add slang</title>
		<link rel="alternate" type="text/html" href="https://wiki.vexillomancy.org/index.php?title=Megachrome&amp;diff=821&amp;oldid=prev"/>
		<updated>2024-09-17T04:48:03Z</updated>

		<summary type="html">&lt;p&gt;add slang&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 04:48, 17 September 2024&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&#039;&#039;&#039;Megachrome&#039;&#039;&#039; is a hypersynthetic stimulant and nootropic discovered in 2993 that is 4,000 times more potent than amphetamine without any cardiovascular side effects and a half life of 43 hours when administered orally.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&#039;&#039;&#039;Megachrome&#039;&#039;&#039; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;(often simply called &#039;&#039;&#039;mega&#039;&#039;&#039;, sometimes euphemistically referred to as &#039;&#039;&#039;MCUltra&#039;&#039;&#039; or simply &#039;&#039;&#039;ultra&#039;&#039;&#039;) &lt;/ins&gt;is a hypersynthetic stimulant and nootropic discovered in 2993 that is 4,000 times more potent than amphetamine without any cardiovascular side effects and a half life of 43 hours when administered orally.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Pharmacokinetics ==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Pharmacokinetics ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Semaiophoron</name></author>
	</entry>
	<entry>
		<id>https://wiki.vexillomancy.org/index.php?title=Megachrome&amp;diff=816&amp;oldid=prev</id>
		<title>Semaiophoron: Created page with &quot;&#039;&#039;&#039;Megachrome&#039;&#039;&#039; is a hypersynthetic stimulant and nootropic discovered in 2993 that is 4,000 times more potent than amphetamine without any cardiovascular side effects and a half life of 43 hours when administered orally.  == Pharmacokinetics == Megachrome exhibits linear time-independent kinetics following single and multiple oral dose administration, with the liver and kidneys both contributing to its breakdown. In addition to its own stimulant effects, it acts as a p...&quot;</title>
		<link rel="alternate" type="text/html" href="https://wiki.vexillomancy.org/index.php?title=Megachrome&amp;diff=816&amp;oldid=prev"/>
		<updated>2024-09-17T03:47:12Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;&amp;#039;&amp;#039;&amp;#039;Megachrome&amp;#039;&amp;#039;&amp;#039; is a hypersynthetic stimulant and nootropic discovered in 2993 that is 4,000 times more potent than amphetamine without any cardiovascular side effects and a half life of 43 hours when administered orally.  == Pharmacokinetics == Megachrome exhibits linear time-independent kinetics following single and multiple oral dose administration, with the liver and kidneys both contributing to its breakdown. In addition to its own stimulant effects, it acts as a p...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Megachrome&amp;#039;&amp;#039;&amp;#039; is a hypersynthetic stimulant and nootropic discovered in 2993 that is 4,000 times more potent than amphetamine without any cardiovascular side effects and a half life of 43 hours when administered orally.&lt;br /&gt;
&lt;br /&gt;
== Pharmacokinetics ==&lt;br /&gt;
Megachrome exhibits linear time-independent kinetics following single and multiple oral dose administration, with the liver and kidneys both contributing to its breakdown. In addition to its own stimulant effects, it acts as a prodrug of a plethora of other known and unknown stimulants.&lt;br /&gt;
&lt;br /&gt;
== Pharmacodynamics ==&lt;br /&gt;
Megachrome has hyperagonist activity at TAAR&amp;lt;sub&amp;gt;1&amp;lt;/sub&amp;gt;, σ&amp;lt;sub&amp;gt;1&amp;lt;/sub&amp;gt;, 5HT&amp;lt;sub&amp;gt;2a&amp;lt;/sub&amp;gt;, most nAChRs, and many other receptors, while acting as a extremely effective Monoamine Reuptake &amp;#039;&amp;#039;Enhancer&amp;#039;&amp;#039;, with total antagonist activity at D&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;R, and completely inhibiting MAO and COMT. It acts as a very strong allosteric modulator for many other receptors, thought to be the cause for the lack of cardiovascular side effects. In addition, it has been noted that the user does not seem to build tolerance to the drug, possibly due to D2R antagonism or unknown secondary mechanisms. Surprisingly, in many cases sensitization to the nootropic and stimulant effects have instead been reported.&lt;br /&gt;
&lt;br /&gt;
Incredible increases in BDNF have been observed in frequent users, but it is unclear if this is through direct pharmacological means, lack of sleep, behavioral changes, or a combination of the three.&lt;br /&gt;
&lt;br /&gt;
Megachrome increases production of NOS, but it also enhances production of PDE5 in equal measure, leading to no noticeable effects. However, many users have suggested that it exhibits highly synergistic effects when combined with extremely high doses of PDE5 inhibitors &lt;br /&gt;
&lt;br /&gt;
== Toxicity ==&lt;br /&gt;
The LD50 for oral consumption in humans has not been determined, but it has been demonstrated that even the most extreme use imaginable does not result in death. Many studies have shown that due to its cardio-optimizing and cardio-stabilizing mechanisms it actually seems to increase longevity in its users.&lt;br /&gt;
&lt;br /&gt;
Concerns have been raised over what has been dubbed &amp;quot;Megapsychosis&amp;quot; in heavy users, with some detractors arguing that the increasingly incomprehensible thoughts after heavy use for several weeks should be considered indicative of neurological damage. But defenders argue that brain scans show a different story, with heavy increases in gray matter, white matter and the corpus callosum, and suggest that detractors are simply not sufficiently advanced to understand the concepts being discussed by heavy users.&lt;/div&gt;</summary>
		<author><name>Semaiophoron</name></author>
	</entry>
</feed>